Press Release
America’s Drug Overdose Epidemic: A Silent Crisis Destroying Lives
The United States is experiencing a drug overdose crisis, with fatalities exceeding 100,000 annually. The increasing prevalence of synthetic opioids, particularly fentanyl, has intensified the situation, resulting in widespread public health concerns.
The Science Behind Addiction: How Drugs Take Control
Substance abuse significantly alters brain function, particularly within the brain’s reward system. By flooding the brain with dopamine, these substances create an artificial sense of pleasure. Over time, dependence develops, reducing the brain’s ability to regulate impulses and decision-making. This process leads to a cycle of addiction that often results in severe consequences.
Drug Overdose: A Growing National Epidemic
Communities across the nation continue to experience the escalating effects of substance abuse. Key statistics highlight the severity of the issue:
- Over 100,000 drug overdose deaths were recorded in 2022.
- Fentanyl, a synthetic opioid 50 times more potent than heroin, is increasingly present in illicit drug supplies.
- Many individuals overdose without awareness of consuming a fatal dose.
Unregulated drug availability, misinformation, and misconceptions about the risks of substance use continue to exacerbate the crisis.
The Consequences of Addiction
Substance abuse has far-reaching consequences beyond individual health impacts. Societal and economic effects include:
- The deterioration of long-term health and cognitive function.
- Increased criminal activity linked to substance dependency.
- The destabilization of families and communities due to addiction-related challenges.
Drug Prevalence Across Communities
Illicit substances have permeated urban, suburban, and rural areas, affecting individuals across all demographics. The proliferation of synthetic drugs and counterfeit pills has heightened the risks associated with substance use, often leading to unintentional overdoses.
The Link Between Drug Abuse and Crime
A strong correlation exists between substance abuse and criminal activity. Addiction can lead to offenses such as theft, assault, and violent crimes. Without intervention, the epidemic continues to contribute to increased crime rates and social instability.
Addressing the Drug Crisis
Efforts to combat addiction require multi-faceted strategies, including:
- Expanding education programs to inform individuals of the dangers of drug use.
- Promoting access to treatment and rehabilitation services.
- Strengthening regulatory measures to curb the distribution of illicit substances.
- Supporting initiatives aimed at substance abuse prevention and recovery.
Public Awareness and Action
Preventative measures and community engagement play essential roles in addressing the ongoing crisis. Collaboration between healthcare professionals, policymakers, and local organizations is necessary to mitigate the impact of drug addiction and prevent further loss of life.
YouTube : https://www.youtube.com/watch?v=IHqRLtC9cJ4
E-Book : https://www.barnesandnoble.com/w/i-did-not-know-brian-keith/1146773753
I Did Not Know
Brian Keith
hismercy37@yahoo.com
http://www.substanceabuseviolence.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/approvals in the U.S., Europe, Canada and Israel.
Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and diagnostic products, announces the receipt of the Medicines & Healthcare products Regulatory Agency (MHRA) approvals for the FemaSeed® Intratubal Insemination product for female infertility treatment and two diagnostic devices, FemVue® for tubal evaluation and FemCerv® for cervical cancer detection.
“This is another key milestone as we expand our reach to the UK following successful approval across Europe for our innovative infertility and cancer detection products.” stated Kathy Lee-Sepsick, Femasys’ CEO. “We remain committed to advancing much-needed options that are safe, effective and cutting-edge for patients globally.”
About FemaSeed
FemaSeed® is an innovative advancement in artificial insemination, designed to enhance fertilization by precisely delivering sperm into the fallopian tube, the natural site of conception. It offers a safe, accessible and cost-effective first-line therapeutic option for infertile women, men and couples seeking pregnancy through insemination. FemaSeed offers a revolutionary alternative to IUI, enabling healthcare professionals to expand their practice services with a more effective approach as demonstrated in the pivotal trial (NCT0468847) for low male sperm count.1 It serves as an affordable, less burdensome and lower-risk first step before IVF. Learn more at www.femaseed.com.
About FemVue
FemVue® is the first FDA-cleared product that creates natural saline and air contrast for a safe, reliable, real-time evaluation of the fallopian tubes using ultrasound. When combined with a uterine cavity assessment, it provides a comprehensive exam in the comfort of the gynecologist’s office. Since FemaSeed infertility treatment requires at least one open fallopian tube, FemVue is an essential companion diagnostic. Learn more at www.femvue.com.
About FemCerv
FemCerv® is the first and only FDA-cleared product purposefully designed to collect a comprehensive and uncontaminated sample in a pain-free office procedure for the detection of cervical cancer. Learn more at www.femcerv.com.
About Femasys
Femasys, an Atlanta-based leading biomedical innovator, develops and commercializes a portfolio of patent-protected, minimally invasive women’s health solutions, all manufactured in the U.S. Our innovative therapeutic and diagnostic products have received global regulatory approvals and are being commercialized in the U.S. and select countries. FemaSeed® Intratubal Insemination, a groundbreaking infertility treatment delivering sperm directly to the site of conception, is U.S. FDA-cleared and approved in Europe, UK, Canada and Israel. FemVue®, a companion diagnostic for fallopian tube assessment via ultrasound, is U.S. FDA-cleared with approvals in Europe, UK, Canada, Japan and Israel. FemCerv®, an endocervical tissue sampler for cervical cancer diagnosis, is U.S. FDA-cleared with approvals in Europe, UK, Canada and Israel. FemBloc® permanent birth control, the Company’s late-stage product candidate, is the first and only non-surgical, in-office, method offering significant benefits over the costly, inconvenient, risk-laden surgical alternative. The pivotal clinical trial (NCT05977751) is now enrolling participants for U.S. approval. FemCath® and FemChec®, companion diagnostic products for FemBloc’s ultrasound-based confirmation test, are U.S. FDA-cleared and approved in Europe and Canada. Learn more at www.femasys.com, or follow us on X, Facebook and LinkedIn.
Reference
1 Liu, J. H., Glassner, M., Gracia, C. R., Johnstone, E. B., Schnell, V. L., Thomas, M. A., L. Morrison, K. Lee-Sepsick (2024). FemaSeed Directional Intratubal Artificial Insemination for Couples with Male-Factor or Unexplained Infertility Associated with Low Male Sperm Count. J Gynecol Reprod Med, 8(2), 01-12.
Forward-Looking Statements
This press release contains forward-looking statements that are subject to substantial risks and uncertainties. Forward-looking statements can be identified by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “pending,” “intend,” “believe,” “suggests,” “potential,” “hope,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on our current expectations and are subject to inherent uncertainties, risks and assumptions, many of which are beyond our control, difficult to predict and could cause actual results to differ materially from what we expect. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ include, among others: our ability to develop and advance our current product candidates and programs into, and successfully initiate, enroll and complete, clinical trials; the ability of our clinical trials to demonstrate safety and effectiveness of our product candidates and other positive results; estimates regarding the total addressable market for our products and product candidates; our ability to commercialize our products and product candidates, our ability to establish, maintain, grow or increase sales and revenues, or the effect of delays in commercializing our products, including FemaSeed; our business model and strategic plans for our products, technologies and business, including our implementation thereof; and those other risks and uncertainties described in the section titled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, and other reports as filed with the SEC. Forward-looking statements contained in this press release are made as of this date, and Femasys undertakes no duty to update such information except as required under applicable law.
Contacts:
Investors:
IR@femasys.com
Media Contact:
Media@femasys.com
Media Contact
Company Name: Femasys Inc.
Contact Person: Media Relations
Email: Media@femasys.com
Website: https://www.femasys.com/
State: Atlanta
Country: United States
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Pacific West Academy Announces Relocation to State-of-the-Art Training Facility Elevating Standards in Executive Protection Training
Pacific West Academy Sets New Standards in Executive Protection Training with State-of-the-Art Facility Relocation in 2025
Van Nuys, California, United States, 11th Feb 2025, – Pacific West Academy, the preeminent institution for executive protection training and bodyguard school, is poised to embark on an exciting new chapter with its scheduled relocation to a state-of-the-art facility in 2025. This transition is emblematic of the academy’s steadfast commitment to delivering the highest caliber of close protection training for individuals aspiring to become close protection agents, as well as those seeking to enhance their skills within the industry. The new facility will have cutting-edge technology, spacious classrooms, advanced simulation rooms, and updated equipment. These enhancements will ensure that students have access to the most contemporary tools and techniques in executive protection, thereby positioning them for success in their professional endeavors.
Owned by Advanced Security Concepts, the leading provider of bodyguard training for celebrities and executives in Los Angeles, California, and beyond, Pacific West Academy is devoted to offering unparalleled training in VIP protection. The move to the new facility underscores both Advanced Security Concepts’ and Pacific West Academy’s commitment to providing comprehensive and innovative training opportunities.
“We are enthusiastic about the myriad possibilities that our new facility will present to our students,” stated Oded Krashinsky, owner of Pacific West Academy. “This relocation exemplifies our unwavering dedication to delivering premier training in celebrity protection and ensuring that our students are thoroughly equipped to succeed in the industry.”
In addition to state-of-the-art technology and expanded training environments, the new facility will include a variety of amenities designed to enhance the student experience. These facilities will feature a modern gym, a swimming pool, and a barbecue area, allowing students to relax and rejuvenate between training sessions. Notably, the facility will house one of the largest and most distinctive force-on-force shoot houses in the country, affording students exceptional hands-on training opportunities.
“Our partnership with Advanced Security Concepts is a source of immense pride, and we are honored to perpetuate the legacy of excellence in EP training,” Krashinsky elaborated. “The inclusion of these remarkable facilities will empower us to elevate our training programs and equip our students with the necessary skills and expertise to thrive in the industry.”
For further information regarding Pacific West Academy and its forthcoming relocation to a new state-of-the-art facility in 2025, please visit www.pwa.edu or contact the academy directly at (818) 906-3753.
Contact person if needed:
Raz Klinghoffer
+13105609782
Media Contact
Organization: Pacific West Academy
Contact
Person: Raz Klinghoffer
Email:
info@pwa.edu
Contact Number: 13105609782
City: Van Nuys
State: California
Country:United States
The post Pacific West Academy Announces Relocation to State-of-the-Art Training Facility Elevating Standards in Executive Protection Training appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Pacific West Academy Announces Relocation to State-of-the-Art Training Facility Elevating Standards in Executive Protection Training
Pacific West Academy Sets New Standards in Executive Protection Training with State-of-the-Art Facility Relocation in 2025
Van Nuys, California, United States, 11th Feb 2025, – Pacific West Academy, the preeminent institution for executive protection training and bodyguard school, is poised to embark on an exciting new chapter with its scheduled relocation to a state-of-the-art facility in 2025. This transition is emblematic of the academy’s steadfast commitment to delivering the highest caliber of close protection training for individuals aspiring to become close protection agents, as well as those seeking to enhance their skills within the industry. The new facility will have cutting-edge technology, spacious classrooms, advanced simulation rooms, and updated equipment. These enhancements will ensure that students have access to the most contemporary tools and techniques in executive protection, thereby positioning them for success in their professional endeavors.
Owned by Advanced Security Concepts, the leading provider of bodyguard training for celebrities and executives in Los Angeles, California, and beyond, Pacific West Academy is devoted to offering unparalleled training in VIP protection. The move to the new facility underscores both Advanced Security Concepts’ and Pacific West Academy’s commitment to providing comprehensive and innovative training opportunities.
“We are enthusiastic about the myriad possibilities that our new facility will present to our students,” stated Oded Krashinsky, owner of Pacific West Academy. “This relocation exemplifies our unwavering dedication to delivering premier training in celebrity protection and ensuring that our students are thoroughly equipped to succeed in the industry.”
In addition to state-of-the-art technology and expanded training environments, the new facility will include a variety of amenities designed to enhance the student experience. These facilities will feature a modern gym, a swimming pool, and a barbecue area, allowing students to relax and rejuvenate between training sessions. Notably, the facility will house one of the largest and most distinctive force-on-force shoot houses in the country, affording students exceptional hands-on training opportunities.
“Our partnership with Advanced Security Concepts is a source of immense pride, and we are honored to perpetuate the legacy of excellence in EP training,” Krashinsky elaborated. “The inclusion of these remarkable facilities will empower us to elevate our training programs and equip our students with the necessary skills and expertise to thrive in the industry.”
For further information regarding Pacific West Academy and its forthcoming relocation to a new state-of-the-art facility in 2025, please visit www.pwa.edu or contact the academy directly at (818) 906-3753.
Contact person if needed:
Raz Klinghoffer
+13105609782
Media Contact
Organization: Pacific West Academy
Contact
Person: Raz Klinghoffer
Email:
info@pwa.edu
Contact Number: 13105609782
City: Van Nuys
State: California
Country:United States
The post Pacific West Academy Announces Relocation to State-of-the-Art Training Facility Elevating Standards in Executive Protection Training appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
Pacific West Academy Announces Relocation to State-of-the-Art Training Facility Elevating Standards in Executive Protection Training
Pacific West Academy Announces Relocation to State-of-the-Art Training Facility Elevating Standards in Executive Protection Training
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Pandora’s Box and Cabo Ella Group Inc Join Forces to Launch “The Perfect 8th”
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release1 week ago
BetBlast AI System Sets New Standards in Sports Data Insights
-
Press Release1 week ago
HEXminer Rises as the Leading Cloud Mining Platform of 2025, Revolutionizing Cryptocurrency Investment
-
Press Release1 week ago
Discover the Power of Prayer with The Reasons I Pray by Deberann Tinson
-
Press Release6 days ago
Miaora CCRMS Alerts Businesses to Escalating ESG Risks in 2025
-
Press Release4 days ago
BioGrowing Shines at IPA World Congress + Probiota 2025, Showcasing Innovations in Probiotics and Postbiotics
-
Press Release4 days ago
Spreadsheet Panda Launches to Empower Excel Users in an AI-Driven World
-
Press Release4 days ago
New York Think Tank Capital Management advances sustainable investments for shared growth
-
Press Release6 days ago
JIFCO Recruitment: Sri Lanka’s Leading Agency Connecting Talent to Global Opportunities